Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors

Overview of attention for article published in Molecular Cancer, January 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter: 5 X users

patent: 2 patents

Citations

dimensions_citation: 69 Dimensions

Readers on

mendeley: 165 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

ENGINEERED NATURAL KILLER CELLS REDIRECTED TOWARD PURINERGIC SIGNALING, CONSTRUCTS THEREOF…

Application EP-3958875-A4

European Patent Office

METHOD OF MODIFYING T CELL(S) IN VITRO OR EX VIVO FOR IMPROVED FUNCTION IN VIVO

Application WO-2019242900-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.